APR 17, 2020 9:15 PM PDT

Overcoming Multi-Drug Resistance in Cancer

WRITTEN BY: Nouran Amin

Resistance to chemotherapeutic use in caner patients is something that is inevitable. Continued resistance to these drugs results in poor prognosis and reduced survival rates.

For the past 35 years, scientists have been aiming to overcome multidrug resistance in cancer through a variety of experimental drugs. Some studies were successful in indicating that blocking the expression of certain genes can fight off tumor resistance to chemotherapeutics. However, that particular strategy has been warned to avoid according to a new research study carried by Scripps Research in Florida.

"With the help of our collaborators at New York University Medical Center, we looked at mouse immune cells from five major lymphoid and nonlymphoid tissues: bone marrow, thymus, spleen, lung, and small intestine," says lead author Mark Sundrud, PhD, associate professor of Immunology and Microbiology at Scripps Research. "It became clear that the types of cells that are key to fighting infections and cancers, are among those most sensitive to blocking MDR1 function."

Learn more about the role of the immune-system in fighting off cancer:

The study indicated that blocking the activity of a key gene, multidrug resistance-1 (MDR1), can hold negative effects on the immune system. These effects target the specialized immune cells called CD8+ cytotoxic T lymphocytes (CTLs).

“These insights become all the more pertinent today, given all the questions and concerns related to immunity against the pandemic coronavirus that causes COVID-19," Sundrud says.

Source: Science Daily

About the Author
  • Nouran is a scientist, educator, and life-long learner with a passion for making science more communicable. When not busy in the lab isolating blood macrophages, she enjoys writing on various STEM topics.
You May Also Like
JUL 27, 2021
Immunology
Rethinking Immune Responses Involved in Skin Hypersensitivity
JUL 27, 2021
Rethinking Immune Responses Involved in Skin Hypersensitivity
A study by immunologists at the University of Copenhagen has revealed a never-before-seen immune pathway invol ...
AUG 01, 2021
Drug Discovery & Development
New Compound Halts Neurodegeneration in Alzheimer's
AUG 01, 2021
New Compound Halts Neurodegeneration in Alzheimer's
Chemists have synthesized new compounds that can halt neurodegeneration linked to Alzheimer’s and other neurologic ...
AUG 02, 2021
Microbiology
The Unique Microbiomes of Long-Lived People
AUG 02, 2021
The Unique Microbiomes of Long-Lived People
What's the secret of people that live a long life? The answer may be complex but for some, it could include the microbio ...
AUG 19, 2021
Drug Discovery & Development
Can drugs increase sociability after pediatric brain injury?
AUG 19, 2021
Can drugs increase sociability after pediatric brain injury?
     Traumatic brain injuries (TBIs) are a leading cause of death and disability in children. In the Unit ...
SEP 12, 2021
Coronavirus
Real-World, Post-Delta COVID-19 Vaccine Data & Potential Treatment
SEP 12, 2021
Real-World, Post-Delta COVID-19 Vaccine Data & Potential Treatment
New research may have identified a potential treatment or preventive medication for SARS-CoV-2 and other viral infection ...
SEP 24, 2021
Drug Discovery & Development
Nasal Drugs Show Promise for Slowing Parkinson's Disease
SEP 24, 2021
Nasal Drugs Show Promise for Slowing Parkinson's Disease
Two drugs delivered via the nose have shown promise for improving symptoms of Parkinson's disease in mice. The corre ...
Loading Comments...